Conference Coverage
S5-E22.2 – Healthy Livers, Healthy Lives: “Political Will” in MASLD Public Policy
Healthy Livers, Healthy Lives’ Chair Jeff Lazarus shares with the Surfers the importance of political will in building a consensus for global MASLD public health policy.
S5-E22.1 – Healthy Livers, Healthy Lives: Why MASHville Needs This Coalition
In this opening conversation, Healthy LIvers, Healthy Lives Chair Jeff Lazarus discusses the goals of the coalition and two initiative to increase early screening.
S5-E21 – Reviewing the Updated ESL-EASD-EASO MASLD Clinical Practice Guidelines
Co-authors Elisabetta Bugianesi and Frank Tacke join Louise Campbell and Roger Green to discuss the new MASLD Clinical Practice Guidelines from EASL, EASDand EASO.
S5-E20.5 – Drug Development Highlights From EASL Congress 2024: Denifenstat, SPECIAL & Other Stories
This conversation covers some of the other major drug development stories from the EASL Congress 2024, with special focus on denifenstat, ION-224 and TAK-227, plus a look at the SPECIAL study on bariatric surgery and cirrhosis.
S5-E20.4 – Drug Development Highlights From EASL Congress 2024: Are FGF-21s Induction Therapy or a “MASH Cure”?
This conversation focuses on the role FGF-21s will play in long-term advanced fibrosis treatment: induction or long-term therapy?
S5-E20.3 – Drug Development Highlights From EASL Congress 2024: “Twin-Cretins” & Efruxifermin
This conversation explores issues regarding incretin agonists and discusses results from the efruxiermin late-breaker at the EASL Congress 2024.